Clearmind starts Phase IIa trial of CMND-100 for alcohol disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to Clearmind starts Phase IIa trial of CMND-100 for alcohol disorder
(NASDAQ: CMND) Delayed: 1.03 -0.13 (11.21%)
Previous Close $1.16    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $0.92    EPS $ 
Volume 2,905,229